Mevidalen

N/A

Report date: 2024/09/18 10:05:27
NME

Base Information

Drug NameMevidalen
Drug Alias NameD1 PAMMevidalen hydroxybenzoateLY-3154207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor modulators
TargetsDopamine D1 receptor
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseLewy Body Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsParkinson DiseaseLewy Body Disease

Other Information

ATC CodeN/A
Related LinksN/A